105 related articles for article (PubMed ID: 2186991)
1. [Inhalation therapy with selective beta 2-sympathomimetic drugs. Effect of pirbuterol administered via the Autohaler and salbutamol administered via the Diskhaler in obstructive respiratory tract disease].
Hoffarth HP; Freyberger H; Völkl KP; Ulmer WT
Fortschr Med; 1990 Mar; 108(8):162-4. PubMed ID: 2186991
[TBL] [Abstract][Full Text] [Related]
2. [Inhaler therapy for adults with obstructive lung diseases: powder or aerosol?].
Dekhuijzen PN
Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1369-74. PubMed ID: 9752023
[TBL] [Abstract][Full Text] [Related]
3. Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response.
Duarte AG; Momii K; Bidani A
Respir Care; 2000 Jul; 45(7):817-23. PubMed ID: 10926377
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing.
Deerojanawong J; Manuyakorn W; Prapphal N; Harnruthakorn C; Sritippayawan S; Samransamruajkit R
Pediatr Pulmonol; 2005 May; 39(5):466-72. PubMed ID: 15786440
[TBL] [Abstract][Full Text] [Related]
5. [Pirbuterol and salbutamol aerosol for exercise-induced bronchoconstriction].
Aebischer JC; Benoit RC; Scherrer M
Schweiz Med Wochenschr; 1984 Nov; 114(46):1660-4. PubMed ID: 6515368
[TBL] [Abstract][Full Text] [Related]
6. [Comparative studies on pirbuterol, salbutamol and a placebo administered as an aerosol in asthmatic patients].
Verstraeten JM
Rev Inst Hyg Mines (Hasselt); 1978; 33(4):200-3. PubMed ID: 552144
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer.
Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G
Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the bronchodilator effect of salbutamol between pressure metered dosed inhaler and dry powder inhaler in patients with stable bronchial asthma].
Yoshimi Y; Fujimura M; Yasui M; Kasahara K; Nakao S
Arerugi; 2004 May; 53(5):502-7. PubMed ID: 15247530
[TBL] [Abstract][Full Text] [Related]
9. [Effect duration and treatment effectiveness of salmeterol, fenoterol and salbutamol in severe forms of respiratory tract obstruction].
Vollmer M; Schmidt EW; Ulmer WT
Pneumologie; 1995 Oct; 49(10):528-34. PubMed ID: 8584522
[TBL] [Abstract][Full Text] [Related]
10. [A new inhalation system for bronchodilatation. Study of the acceptance of the Ingelheim M inhaler in chronic obstructive respiratory tract diseases].
Mütterlein R; Schmidt G; Fleischer W; Freund E
Fortschr Med; 1990 Apr; 108(11):225-8. PubMed ID: 2141590
[TBL] [Abstract][Full Text] [Related]
11. Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol.
Tinkelman DG; Brandon ML; Grieco M; Hudson L; Rosenthal RR; Spector SL; Tashkin D; Votteri B
Ann Allergy; 1990 Feb; 64(2 Pt 2):202-6. PubMed ID: 2405746
[TBL] [Abstract][Full Text] [Related]
12. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
Eiser NM; Phillips C; Wooler PA
Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
[TBL] [Abstract][Full Text] [Related]
13. Clinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating effects of salbutamol.
Vidgren M; Silvasti M; Korhonen P; Kinkelin A; Frischer B; Stern K
Arzneimittelforschung; 1995 Jan; 45(1):44-7. PubMed ID: 7893268
[TBL] [Abstract][Full Text] [Related]
14. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
Lindberg A; Szalai Z; Pullerits T; Radeczky E
Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
[TBL] [Abstract][Full Text] [Related]
15. [A technical inhalation test variant for improving the effectiveness of the use of dose aerosols].
Gregori P
Z Erkr Atmungsorgane; 1990; 174(3):190-5. PubMed ID: 1975966
[TBL] [Abstract][Full Text] [Related]
16. [Responder and non-responder in the bronchodilator test?].
Vollmer M; Schmidt EW; Ulmer WT
Pneumologie; 1995 Nov; 49(11):584-9. PubMed ID: 8584530
[TBL] [Abstract][Full Text] [Related]
17. The role of domiciliary nebulizers in managing patients with severe COPD.
Eiser N; Angus K; McHale S
Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
[TBL] [Abstract][Full Text] [Related]
18. [Response to inhaled bronchodilators in chronic airway obstruction].
Holten K
Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284
[TBL] [Abstract][Full Text] [Related]
19. Comparative investigations on pirbuterol, salbutamol and placebo aerosols in bronchial asthma.
Beumer HM
Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):237-9. PubMed ID: 381220
[TBL] [Abstract][Full Text] [Related]
20. Salbutamol powder inhaled from the Diskhaler compared to salbutamol as nebulizer solution in severe chronic airways obstruction.
Hansen NC; Andersen PB
Respir Med; 1995 Mar; 89(3):175-9. PubMed ID: 7746909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
